Literature DB >> 35767164

Quality of life impairment after a diagnosis of Cushing's syndrome.

Susan M Webb1, Elena Valassi2.   

Abstract

This brief review is devoted mainly to publications in the last 5 years dealing with health-related quality of life (QoL) after a diagnosis of endogenous hypercortisolism, due to pituitary-dependent Cushing's disease (CD) or any other cause of Cushing syndrome (CS). Despite improvement after treatment, persistent physical morbidity, neurocognitive problems like worse executive capacity and memory as well as stress intolerance, depressive symptoms and more anxiety, lead to long-term impairment of QoL.
© 2022. The Author(s).

Entities:  

Keywords:  Anxiety; Cushing syndrome; Depression; Emotional distress; Memory impairment; Quality of life

Year:  2022        PMID: 35767164     DOI: 10.1007/s11102-022-01245-9

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   3.599


  16 in total

Review 1.  Quality of life in Cushing's syndrome.

Authors:  Margot Mc Bride; Iris Crespo; Susan M Webb; Elena Valassi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2021-02-17       Impact factor: 4.690

2.  Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN.

Authors:  Elena Valassi; Richard Feelders; Dominique Maiter; Philippe Chanson; Maria Yaneva; Martin Reincke; Michal Krsek; Miklós Tóth; Susan M Webb; Alicia Santos; Isabel Paiva; Irina Komerdus; Michael Droste; Antoine Tabarin; Christian J Strasburger; Holger Franz; Peter J Trainer; John Newell-Price; John Ah Wass; Eleni Papakokkinou; Oskar Ragnarsson
Journal:  Clin Endocrinol (Oxf)       Date:  2018-04-16       Impact factor: 3.478

3.  Improvement but No Normalization of Quality of Life and Cognitive Functioning After Treatment of Cushing Syndrome.

Authors:  Leonie H A Broersen; Cornelie D Andela; Olaf M Dekkers; Alberto M Pereira; Nienke R Biermasz
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

4.  Hippocampal Volume, Cognitive Functions, Depression, Anxiety, and Quality of Life in Patients With Cushing Syndrome.

Authors:  Katrine Emilie Frimodt-Møller; Jens Richardt Møllegaard Jepsen; Ulla Feldt-Rasmussen; Jesper Krogh
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

Review 5.  Psychiatric Symptoms in Patients with Cushing's Syndrome: Prevalence, Diagnosis and Management.

Authors:  Alicia Santos; Eugenia Resmini; Juan Carlos Pascual; Iris Crespo; Susan M Webb
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

6.  Evaluation of an individualized education program in pituitary diseases: a pilot study.

Authors:  F Albarel; I Pellegrini; H Rahabi; C Baccou; L Gonin; C Rochette; M Vermalle; T Cuny; F Castinetti; T Brue
Journal:  Eur J Endocrinol       Date:  2020-12       Impact factor: 6.664

7.  Enhanced self-efficacy after a self-management programme in pituitary disease: a randomized controlled trial.

Authors:  Cornelie D Andela; Han Repping-Wuts; Nike M M L Stikkelbroeck; Mathilde C Pronk; Jitske Tiemensma; Ad R Hermus; Adrian A Kaptein; Alberto M Pereira; Noelle G A Kamminga; Nienke R Biermasz
Journal:  Eur J Endocrinol       Date:  2017-07       Impact factor: 6.664

Review 8.  Psychiatric and neurocognitive consequences of endogenous hypercortisolism.

Authors:  M Piasecka; E Papakokkinou; E Valassi; A Santos; S M Webb; F de Vries; A M Pereira; O Ragnarsson
Journal:  J Intern Med       Date:  2020-04-29       Impact factor: 8.989

9.  Illustration of patient-reported outcome challenges and solutions in rare diseases: a systematic review in Cushing's syndrome.

Authors:  Naomi Knoble; Gabrielle Nayroles; Cherry Cheng; Benoit Arnould
Journal:  Orphanet J Rare Dis       Date:  2018-12-19       Impact factor: 4.123

10.  Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome.

Authors:  Rachel Acree; Caitlin M Miller; Brent S Abel; Nicola M Neary; Karen Campbell; Lynnette K Nieman
Journal:  J Endocr Soc       Date:  2021-06-14
View more
  1 in total

1.  Special issue: Cushing's disease update.

Authors:  Maria Fleseriu
Journal:  Pituitary       Date:  2022-08-24       Impact factor: 3.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.